Evolution of nonbasic thienopyrimidinone containing alcohols as selective MCHR1 antagonists culminating in the discovery of the clinical candidate BMS-830216
journal contribution
posted on 2024-04-08, 05:21authored byWilliam N Washburn, Mark Manfredi, Pratik Devasthale, Guohua Zhao, Saleem Ahmad, Andres Hernandez, Jeffrey A Robl, Wei Wang, James Mignone, Zhenghua Wang, Khehyong Ngu, Mary Ann Pelleymounter, Daniel Longhi, Ning Huang, Neil Flynn, Anthony V Azzara, Joel C Barrish, Kenneth Rohrbach, James Devenny, Suzanne Rooney, Michael Thomas, Susan Glick, Helen Godonis, Susan Harvey, Mary Jane Cullen, Simeon TaylorSimeon Taylor, Hongwei Zhang, Christian Caporuscio, Paul Stetsko, Mary Grubb, Brad D Maxwell, Hong Yang, Atsu Apedo, Brian Gemzik, Evan Janovitch, Christine Huang, Lisa Zhang, Chris Freeden, Brian J Murphy
Evolution of nonbasic thienopyrimidinone containing alcohols as selective MCHR1 antagonists culminating in the discovery of the clinical candidate BMS-830216
History
Journal
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY